FDA 483 Listing Observations - Mostly Corrective Action and Root Causes?

sreenu927

Quite Involved in Discussions
#1
Hi All..
Most of the 483 listing observations include " CAPA procedures are not adequately established" and/or "Complaint handling procedures are not adequately established with no designated unit".

In such cases, usually what could be the root cause, other than the lack of understanding or misinterpretation of regulatory requirements?

I am just thinking further down and down and understood (may be wrong!!) that the potential root cause could be "misinterpretation of requirements".

The other observations like, "acceptance activities are not documented" and "Unapproved documents/editable docs were found to be use in ..". In these cases, the root cause is "lack of training on the use of documents or completing documents".

Any thoughts?

Regards,
Sreenu
 
Elsmar Forum Sponsor

TWA - not the airline

Trusted Information Resource
#3
You could still dig deeper: Why do people responsible for authoring prodecures lack the necessary regulatory knowledge? Inadequate training procedures? Ressource issues escaping management's awareness?
Or: Why do inadequate procedures get approved? Doc control issue, procedure does not call for QA/RA review approval? Such practices should be found by internal audits, so why did they not? So again a management review issue?

The thing is, that in the end it is the responsibility of management to ensure that the QMS is working, so if it is a systematic problem the real root cause is always management (unfortunately typically only external auditors can tell that to their face:argue:). If it is a single event it could be anything; however for single events you may only need to correct the problem and not perform a full root cause analysis to get down to the systematic error (and for preventive action start with management...:notme:)
 
M

MIREGMGR

#4
My understanding is that in most audits where those findings are included, the inspector determines that the company either doesn't have a real quality system at all, or has only the minimum system that they think might be enough to fend off FDA...in both cases, usually because the owner or management think that regulation is a waste of time and money and an imposition on their freedom to do whatever they want.
 
M

mr.mike

#5
MIREGMGR, maybe this is the case for some, but I'd like to think stating this is the case for "most" such findings would be overly cynical....

As our FDA inspector explained, when issuing a 483, for each observation the inspector must select from a pre-defined list of observation headings. As such, relatively minor (or as the original poster mentions, misinterpretations/misunderstandings) may be listed under headings which may (unfortunately) give the impression of gross gaps in the system.

For example from ours:

"Procedures for management review have not been adequately established."
...but the actual observation was only that we were just listing attendees, and not getting actual signatures (proof) of attendance.

I have a feeling that most 483s with observations like "procedures for X have not been adequately established" are in fact misinterpretations/misunderstandings of FDA expectations, rather than gross, deliberate negligence.

...but maybe I'm just overly optimistic... :)
 
Thread starter Similar threads Forum Replies Date
J Manufacturing CRL - Class 1 or Class 2 Inspection (FDA form 483) US Food and Drug Administration (FDA) 1
R Is it a requirement to notify my customer if I receive a 483 from the FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 6
J FDA 483 Warning Letter for use of Calipers 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 18
S What are the next steps after providing response to FDA 483 ? US Food and Drug Administration (FDA) 7
T FDA Form 483 Warning Letter - What next? US Food and Drug Administration (FDA) 7
S FDA Forms 482, 483 and 484 - MS Word documents US Food and Drug Administration (FDA) 6
K Where you can read other companys' 483 FDA Warning Letters 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 4
A FDA 483 Warning Letter Response Time Requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
E 483 Process Validation - FDA Audit Observation 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
E How to Respond to a US FDA untitled letter - Form 483 or Warning Letter Other US Medical Device Regulations 2
C Response by FDA for Form 483 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 8
U Response to FDA 483. Responded within 14 days and now waiting for reply US Food and Drug Administration (FDA) 7
E FDA - Audit - Response - Observation form 483. Do we now receive a formal letter? US Food and Drug Administration (FDA) 5
C Non-sterile reusable surgical instruments - FDA sterilization requirement Other Medical Device Related Standards 2
D FDA Information - Revising the Instructions for Use US Food and Drug Administration (FDA) 0
S Transitional Adolescent A and B - "CDRH PREMARKET REVIEW SUBMISSION COVER SHEET FORM FDA 3514" Medical Device and FDA Regulations and Standards News 1
B FDA requirement for CAPA Signoff ISO 13485:2016 - Medical Device Quality Management Systems 6
P MSDS for MVQ FDA White, Vinyl Methyl Silicone Rubber EU Medical Device Regulations 4
S Manufacturing Process FDA FOIA Medical Device and FDA Regulations and Standards News 3
S Manufacturing Process FDA FOIA US Food and Drug Administration (FDA) 4
S Mechanical Test Under FDA Freedom of Information Act Medical Device and FDA Regulations and Standards News 5
A Medical Device Contract Manufacturer - Does the CM need to register with FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
M Supplier requirements - Major supplier is a Non-Profit registered with ICCBBA (FDA UDI) Supply Chain Security Management Systems 12
C RA (Regulatory Assurance) Training (FDA) looking for resources Training - Internal, External, Online and Distance Learning 5
E FDA 513(g) Cover Letter US Food and Drug Administration (FDA) 5
S Records - Do's and don't' of record entries (FDA - 21 CFR 820) Records and Data - Quality, Legal and Other Evidence 13
B New Facility register with FDA Pharmaceuticals (21 CFR Part 210, 21 CFR Part 211 and related Regulations) 4
K 510k FDA review, will they accept Biocompatibility result generated using feasibility product lots? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 8
J FDA regulation on decorative contact lenses Medical Device and FDA Regulations and Standards News 5
P Anyone have an Idea on UAE Medical device registeration- Class B with FDA only Other Medical Device Regulations World-Wide 0
F FDA classification for a mobile app Medical Information Technology, Medical Software and Health Informatics 3
Ed Panek IFU Contact Requirements - FDA and MDD/MDR US Food and Drug Administration (FDA) 1
O Any info on release date of FDA “Computer Software Assurance for Manufacturing and Quality System Software” document? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
P Writing a presubmission to the FDA prior to the De novo submission US Food and Drug Administration (FDA) 4
K FDA - Can we have more than 1 Initial Importer Medical Device and FDA Regulations and Standards News 4
K Two FDA questions regarding UDI (and potentially 803.52 MDR) Other US Medical Device Regulations 0
R Importers - For the FDA Registration/ Listing, is the CMO the importer? Medical Device and FDA Regulations and Standards News 6
Z Iterative development and FDA change requests IEC 62304 - Medical Device Software Life Cycle Processes 12
P FDA Approved Product Contact Parts ISO 13485:2016 - Medical Device Quality Management Systems 6
O Clarifying FDA definition of "finished device" and “capable of functioning” 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
A FDA guidance on non-sterile Medical Device Packaging Medical Device and FDA Regulations and Standards News 7
JoCam FDA Registration for Sub-contract manufacturers Medical Device and FDA Regulations and Standards News 2
M FDA News FDA Releases Draft Guidance Clarifying Application of ISO 10993-1 Biocompatibility Standard Medical Device and FDA Regulations and Standards News 0
M Is IEC 60601-1-2 required by FDA for all electronic medical devices? IEC 60601 - Medical Electrical Equipment Safety Standards Series 1
E Contract manufacturer FDA requirements foreign company US Food and Drug Administration (FDA) 6
P Choice of FDA reviewer US Food and Drug Administration (FDA) 6
J Is Device Tracking Card an actual requirement under FDA regulation? Other US Medical Device Regulations 0
T Definition Human Use (FDA) Definitions, Acronyms, Abbreviations and Interpretations Listed Alphabetically 7
K FDA 510k electrosurgery 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
J Leveraging FDA 510k Clearance for International Registrations Other Medical Device Regulations World-Wide 2

Similar threads

Top Bottom